U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
MABT-5102A
Preferred Name English
CRENEZUMAB
INN   USAN   WHO-DD  
INN   USAN  
Official Name English
CRENEZUMAB [USAN]
Common Name English
MABT5102A
Code English
IMMUNOGLOBULIN G4, ANTI-(HUMAN 1-40-.BETA.-AMYLOID/HUMAN 1-42-.BETA.-AMYLOID) (HUMAN-MOUSE MONOCLONAL MABT5102A HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL MABT5102A LIGHT CHAIN, DIMER
Common Name English
Crenezumab [WHO-DD]
Common Name English
RG7412
Code English
CRENEZUMAB [JAN]
Common Name English
crenezumab [INN]
Common Name English
RG-7412
Code English
Code System Code Type Description
FDA UNII
O8AS5277H0
Created by admin on Mon Mar 31 20:31:08 GMT 2025 , Edited by admin on Mon Mar 31 20:31:08 GMT 2025
PRIMARY
ChEMBL
CHEMBL1743004
Created by admin on Mon Mar 31 20:31:08 GMT 2025 , Edited by admin on Mon Mar 31 20:31:08 GMT 2025
PRIMARY
ChEMBL
CHEMBL2109301
Created by admin on Mon Mar 31 20:31:08 GMT 2025 , Edited by admin on Mon Mar 31 20:31:08 GMT 2025
PRIMARY
NCI_THESAURUS
C174789
Created by admin on Mon Mar 31 20:31:08 GMT 2025 , Edited by admin on Mon Mar 31 20:31:08 GMT 2025
PRIMARY
DRUG BANK
DB11959
Created by admin on Mon Mar 31 20:31:08 GMT 2025 , Edited by admin on Mon Mar 31 20:31:08 GMT 2025
PRIMARY
CAS
1095207-05-8
Created by admin on Mon Mar 31 20:31:08 GMT 2025 , Edited by admin on Mon Mar 31 20:31:08 GMT 2025
PRIMARY
WIKIPEDIA
CRENEZUMAB
Created by admin on Mon Mar 31 20:31:08 GMT 2025 , Edited by admin on Mon Mar 31 20:31:08 GMT 2025
PRIMARY
SMS_ID
100000138890
Created by admin on Mon Mar 31 20:31:08 GMT 2025 , Edited by admin on Mon Mar 31 20:31:08 GMT 2025
PRIMARY
EVMPD
SUB79293
Created by admin on Mon Mar 31 20:31:08 GMT 2025 , Edited by admin on Mon Mar 31 20:31:08 GMT 2025
PRIMARY
USAN
WW-113
Created by admin on Mon Mar 31 20:31:08 GMT 2025 , Edited by admin on Mon Mar 31 20:31:08 GMT 2025
PRIMARY
INN
9482
Created by admin on Mon Mar 31 20:31:08 GMT 2025 , Edited by admin on Mon Mar 31 20:31:08 GMT 2025
PRIMARY
ACTIVE MOIETY
CRENEZUMAB
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966